Back to blog

Product Updates

How DermAI's Image Recognition Model Works

A product-level walkthrough of photo capture, preprocessing, visual model review, triage, and report generation.

Drew PattersonOctober 8, 202410 min read
AI and clinical technology workspace with monitors

Key takeaways

The scan pipeline starts with photo quality and consent.
The model reviews visible patterns, then the product layer adds context and safety rules.
Reports emphasize next steps, uncertainty, and clinician handoff.

The scan starts before the model

A strong AI result starts with a usable image. DermAI checks whether the photo is sharp enough, bright enough, and framed with enough surrounding skin to understand the visible pattern. It also asks for body area, duration, symptoms, and whether any urgent warning signs are present. These inputs are not decoration; they directly shape the report.

Before analysis, image metadata such as location-related EXIF should be stripped when technically feasible. Raw image handling should be consent-led, with clear choices for analyze-and-delete, saved history, reports, and support review. Skin photos are sensitive even when they seem ordinary.

What the model reads

The visual model reviews features such as color distribution, border shape, texture, scale, bump pattern, lesion symmetry, and whether the image quality makes the result unreliable. It compares the scan with learned examples from labeled dermatology patterns, then produces probabilities rather than a single medical statement.

Those probabilities are only one layer. DermAI then applies product logic around confidence, urgency, unsupported use, medical disclaimers, and next steps. A high-confidence low-risk inflammatory pattern may produce monitoring guidance. A lower-confidence mole concern may still produce prompt review guidance because the consequence of missing risk is higher.

Why top-3 matters

Skin conditions overlap. Showing only the highest probability can make the system look more certain than it is. A top-3 view helps users understand what else might explain the image and why the app may ask for clinician review. It also helps clinicians see how the report framed the case.

This is not about making users diagnose themselves. It is about making uncertainty visible. The report should explain which signs support the leading possibility and which signs keep alternatives in the differential.

From result to care pathway

The final output combines the model signal, symptom context, and safety rules into a report: likely patterns, confidence, urgency, explanation, photo-quality notes, and recommended next actions. For Pro members, scan history and PDF exports can turn scattered skin events into a useful timeline.

The best version of DermAI is not a black box. It is a guided path from "I noticed something" to "I know what to do next," while making clear that diagnosis and treatment decisions belong with qualified medical professionals.

Scan CTA

Turn a skin concern into organized next steps.

DermAI can help capture the photo, document symptom context, and prepare a clearer report for monitoring or clinical review.